mcrpc: latest developments in diagnostics and combination therapies
Published 2 years ago • 123 plays • Length 27:02Download video MP4
Download video MP3
Similar videos
-
46:50
mcrpc and nmcrpc: combinations and latest data, what does covid mean for early treatment?
-
25:53
developments in metastatic hormone-sensitive prostate cancer
-
2:41
recent developments in treatment options for castration-sensitive metastatic prostate cancer
-
33:19
castration resistant prostate cancer - developments and challenges from 2020
-
17:44
asco 2021: latest on parpi and other treatments for mcrpc
-
15:19
latest developments in metastatic prostate cancer from esmo 2019
-
18:54
asco 2018: latest developments in non-metastatic & metastatic castration-resistant prostate cancer
-
11:00
treatment approaches for newly diagnosed mcrpc
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
17:19
prostate cancer debate 2014: evolving treatment options in castration-resistant prostate cancer
-
18:57
disease management for mcrpc
-
3:55
optimal treatment approaches for mcrpc
-
3:07
current developments in castration-resistant prostate cancer therapies
-
32:56
prostate cancer debate: treatment strategies and options in castration-resistant prostate cancer
-
1:04:24
urowebinar: new treatment options in mcrpc
-
18:40
asco 2015: latest developments in prostate cancer treatment
-
4:21
phase ii results of olaparib and abiraterone for mcrpc
-
39:15
aua: sequencing of agents and combination therapy in castrate resistant prostate cancer
-
28:26
key developments in prostate cancer